Cardiology

Ezetimibe not tied to higher cancer risk, mortality

(HealthDay)—Treatment with the lipid-lowering therapy ezetimibe/simvastatin is not associated with an increased risk of developing cancer or an increased risk of dying from cancer, according to research published in the ...

Cardiology

Valve replacement via catheterization is gaining ground

When Maryann Casey battled breast cancer more than 30 years ago, her doctors warned that the radiation therapy could damage her heart. Still, she was caught off guard when, after an echocardiogram in 2012, she was diagnosed ...

Cardiology

Self-expanding TAVR widens advantage over surgery at two years

Two-year data show a continued survival advantage for self-expanding transcatheter aortic valve replacement (TAVR) over standard surgery in high-risk patients with severe aortic stenosis, according to research presented at ...

Cardiology

Results of US CoreValve High Risk Trial reported at TCT 2014

According to a new study, transcatheter aortic valve replacement (TAVR) provided meaningful clinical benefits relative to surgical aortic valve replacement (SAVR) in high risk patients with incremental costs considered acceptable ...

Cardiology

Women less likely to die after TAVI than men

Women are 25 percent less likely to die one year after TAVI than men, according to research presented at the ESC Congress today by Dr. Mohammad Sherif from Germany. The findings suggest that TAVI might be the preferred treatment ...

Cardiology

Medicare changes may increase access to TAVR

People with aortic stenosis and a low surgical risk became eligible for a less invasive valve replacement last summer, spurring increased demand for the catheter-based procedure called TAVR. But only a subset of U.S. hospitals, ...

Cardiology

Results from the SENTINEL trial presented

A multicenter randomized trial evaluating the role of embolic protection using the Sentinel device during transcatheter aortic valve replacement (TAVR) found that the device was safe but did not meet the primary efficacy ...

page 14 from 19